Kronik2008 - Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics Lab
About lab
This mathematical model describes interactions between glioma tumors and the immune system that may occur following direct intra-tumoral administration of ex-vivo activated alloreactive cytotoxic-T-ly. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.
Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagekronik2008-improving-alloreactive-ctl-immunotherapy-for-malignan
Created2026-05-15
Updated2026-05-15
immunologysbmlbiomodels_ebifaithfulcuratedvisualisation
Manifest
{
"io": {
"inputs": [
{
"name": "initial_unresolved_tumor_observable_1",
"label": "Initial Unresolved Tumor Observable 1",
"units": "native source value",
"default": 10000000000,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.initial_unresolved_tumor_observable_1",
"description": "Initial Unresolved Tumor Observable 1. Sets the initial value of bundled SBML species `T`."
},
{
"name": "initial_unresolved_tumor_observable_2",
"label": "Initial Unresolved Tumor Observable 2",
"units": "native source value",
"default": 2000000,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.initial_unresolved_tumor_observable_2",
"description": "Initial Unresolved Tumor Observable 2. Sets the initial value of bundled SBML species `C`."
},
{
"name": "initial_unresolved_tumor_observable_3",
"label": "Initial Unresolved Tumor Observable 3",
"units": "native source value",
"default": 0,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.initial_unresolved_tumor_observable_3",
"description": "Initial Unresolved Tumor Observable 3. Sets the initial value of bundled SBML species `F_beta`."
},
{
"name": "initial_unresolved_tumor_observable_4",
"label": "Initial Unresolved Tumor Observable 4",
"units": "native source value",
"default": 0,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.initial_unresolved_tumor_observable_4",
"description": "Initial Unresolved Tumor Observable 4. Sets the initial value of bundled SBML species `F_gamma`."
},
{
"name": "initial_unresolved_tumor_observable_5",
"label": "Initial Unresolved Tumor Observable 5",
"units": "native source value",
"default": 0,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.initial_unresolved_tumor_observable_5",
"description": "Initial Unresolved Tumor Observable 5. Sets the initial value of bundled SBML species `M1`."
},
{
"name": "tumor_growth_rate",
"label": "Tumor Growth Rate",
"units": "native source value",
"default": 0.00035,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.tumor_growth_rate",
"description": "Tumor Growth Rate. Sets bundled SBML parameter `r`."
},
{
"name": "s_dose",
"label": "S Dose",
"units": "native source value",
"default": 300000000,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.s_dose",
"description": "S Dose. Sets bundled SBML parameter `S_dose`."
},
{
"name": "s_dose_initial_parameter",
"label": "S Dose Initial Parameter",
"units": "native source value",
"default": 300000000,
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.s_dose_initial_parameter",
"description": "S Dose Initial Parameter. Sets bundled SBML parameter `ModelValue_28`."
}
],
"outputs": [
{
"name": "unresolved_tumor_observable_1",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.unresolved_tumor_observable_1"
},
{
"name": "unresolved_tumor_observable_2",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.unresolved_tumor_observable_2"
},
{
"name": "unresolved_tumor_observable_3",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.unresolved_tumor_observable_3"
},
{
"name": "unresolved_tumor_observable_4",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.unresolved_tumor_observable_4"
},
{
"name": "unresolved_tumor_observable_5",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.unresolved_tumor_observable_5"
},
{
"name": "state",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.state"
},
{
"name": "summary",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.summary"
},
{
"name": "species_labels",
"maps_to": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.species_labels"
}
]
},
"title": "Kronik2008 - Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics Lab",
"models": [
{
"path": "owned/models/immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model",
"alias": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model",
"provenance": {
"owned_path": "owned/models/immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model"
}
},
{
"path": "owned/models/visualisation",
"alias": "visualisation",
"provenance": {
"owned_path": "owned/models/visualisation"
}
}
],
"wiring": [
{
"to": [
"visualisation.immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model_state"
],
"from": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.state"
},
{
"to": [
"visualisation.immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model_summary"
],
"from": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.summary"
},
{
"to": [
"visualisation.immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model_species_labels"
],
"from": "immunology_sbml_kronik2008_improving_alloreactive_ctl_immunother_biomd0000000808_model.species_labels"
}
],
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"description": "This mathematical model describes interactions between glioma tumors and the immune system that may occur following direct intra-tumoral administration of ex-vivo activated alloreactive cytotoxic-T-ly. It can be used to explore immune response dynamics and compare pathway-level behavior across conditions.",
"schema_version": "2.0"
}Sign in to start your own run. Public-lab history stays visible here.
Select a run from History to view its results.